{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T04:59:32Z","timestamp":1784264372656,"version":"3.55.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1016\/j.ijrobp.2010.05.022","type":"journal-article","created":{"date-parts":[[2010,8,22]],"date-time":"2010-08-22T08:49:54Z","timestamp":1282466994000},"page":"353-359","source":"Crossref","is-referenced-by-count":25,"title":["Failure Rates and Patterns of Recurrence in Patients With Resected N1 Non\u2013Small-Cell Lung Cancer"],"prefix":"10.1016","volume":"81","author":[{"given":"John M.","family":"Varlotto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura Nyshel","family":"Medford-Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abram","family":"Recht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John C.","family":"Flickinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Schaefer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malcolm M.","family":"DeCamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2010.05.022_bib1","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1056\/NEJMoa031644","article-title":"Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small cell lung cancer","volume":"350","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2010.05.022_bib2","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1056\/NEJMoa043623","article-title":"Vinorelbine plus cisplatin vs. observation in resected non-small cell lung cancer","volume":"352","author":"Winton","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2010.05.022_bib3","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/S1470-2045(06)70804-X","article-title":"Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): A randomised controlled trial","volume":"7","author":"Douillard","year":"2006","journal-title":"Lancet Oncol"},{"issue":"18S","key":"10.1016\/j.ijrobp.2010.05.022_bib4","first-page":"365S","article-title":"Adjuvant chemotherapy in Stage IB non-small cell lung cancer: Update of CALGB protocol 9633(abstract 7007)","volume":"24","author":"Strauss","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2010.05.022_bib5","doi-asserted-by":"crossref","first-page":"5043","DOI":"10.1200\/JCO.2008.16.4855","article-title":"Adjuvant paclitaxel plus carboplatin compared with observation in stage IB non-small-cell lung cancer: CALGB 9633 with the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups","volume":"26","author":"Strauss","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2010.05.022_bib6","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1200\/JCO.2009.23.2272","article-title":"Long-term results of the International Adjuvant Lung Cancer Trial evaluating adjuvant cisplatin-based chemotherapy in resected lung cancer","volume":"28","author":"Arriagada","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2010.05.022_bib7","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1200\/JCO.2009.24.0333","article-title":"Randomized phase III trial of vinorelbine plus cisplatin compared with observation in completely resected stage IB and II non-small cell lung cancer: Updated survival analysis of JBR-10","volume":"28","author":"Butts","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2010.05.022_bib8","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1002\/cncr.24133","article-title":"Factors associated with local and distant recurrence and survival in patients with resected non-small cell lung cancer","volume":"115","author":"Varlotto","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2010.05.022_bib9","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1002\/cncr.25047","article-title":"Varying recurrence rates and risk factors associated with different definitions of local recurrence in patients with surgically-resected Stage I non-small cell lung cancer","volume":"116","author":"Varlotto","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2010.05.022_bib10","unstructured":"Surveillance, Epidemiology, and End Results (SEER) program public-use data (1973-2006), National Cancer Institute, DCCPS, Surveillance Research Statistics Branch. Available at: http:\/\/seer.cancer.gov\/publicdata\/. Accessed October 3, 2009."},{"key":"10.1016\/j.ijrobp.2010.05.022_bib11","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1200\/JCO.1994.12.2.360","article-title":"Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small cell lung cancer: Results of a European multicenter trial including 612 patients","volume":"12","author":"LeChevalier","year":"1994","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2010.05.022_bib12","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1093\/annonc\/mdf332","article-title":"Phase III randomized trial comparing paclitaxel\/carboplatin with paclitaxel\/cisplatin in patients with advanced non-small cell lung cancer: A cooperative multinational trial","volume":"13","author":"Rosell","year":"2002","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ijrobp.2010.05.022_bib13","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1093\/jnci\/djk196","article-title":"Cisplatin- versus carboplatin-based chemotherapy in first-line treatment of advanced non-small cell lung cancer: An individual patient data meta-analysis","volume":"99","author":"Ardizzoni","year":"2007","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ijrobp.2010.05.022_bib14","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1634\/theoncologist.2008-0260","article-title":"Impact of third-generation drugs on the activity of first-line chemotherapy in advanced non-small cell lung cancer: A meta-analytical approach","volume":"14","author":"Grossi","year":"2009","journal-title":"Oncologist"},{"key":"10.1016\/j.ijrobp.2010.05.022_bib15","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/JTO.0b013e3181c814e7","article-title":"Adjuvant cisplatin and vinorelbine for completely resected non-small cell lung cancer: Subgroup analysis of the lung adjuvant cisplatin evaluation","volume":"5","author":"Douillard","year":"2010","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.ijrobp.2010.05.022_bib16","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0140-6736(98)06341-7","article-title":"Postoperative radiotherapy in non-small-cell lung cancer: Systematic review and meta-analysis of individual patient data from nine randomised controlled trials","volume":"352","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.ijrobp.2010.05.022_bib17","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.ijrobp.2008.01.044","volume":"72","author":"Douillard","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2010.05.022_bib18","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.lungcan.2004.11.007","volume":"48","author":"Wakelee","year":"2005","journal-title":"Lung Cancer"},{"key":"10.1016\/j.ijrobp.2010.05.022_bib19","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0167-8140(01)00478-9","article-title":"Adjuvant radiotherapy in non-small cell lung cancer with pathological Stage I: Definitive results of a phase III randomized trial","volume":"62","author":"Trodella","year":"2002","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2010.05.022_bib20","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/j.athoracsur.2003.07.040","article-title":"Sleeve lobectomy versus pneumonectomy for lung cancer: A comparative analysis of survival and sites or recurrences","volume":"77","author":"Deslauriers","year":"2004","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.ijrobp.2010.05.022_bib21","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1002\/(SICI)1097-0142(19961115)78:10<2111::AID-CNCR11>3.0.CO;2-1","article-title":"Blood vessel and lymphatic vessel invasion in resected non-small cell lung carcinoma: Correlation with TNM stage and disease free and overall survival","volume":"78","author":"Brechot","year":"1996","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2010.05.022_bib22","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1378\/chest.108.1.246","article-title":"New prognostic factors in lung cancer: Biologic prophets of cancer cell aggression","volume":"108","author":"Mountain","year":"1995","journal-title":"Chest"},{"key":"10.1016\/j.ijrobp.2010.05.022_bib23","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1378\/chest.117.2.374","article-title":"Prognostic assessment of 2,361 patients who underwent pulmonary resection for non-small cell lung cancer, stage I, II, and IIIA","volume":"117","author":"de la Rivi\u00e8re","year":"2000","journal-title":"Chest"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301610007455?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301610007455?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,3,29]],"date-time":"2024-03-29T20:42:48Z","timestamp":1711744968000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301610007455"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["S0360301610007455"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2010.05.022","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10]]}}}